Phase
Condition
Chest Pain
Heart Disease
Heart Defect
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: One of the following VT events (within the last 6 months) + Ejection Fraction <40%: A: ≥3 episodes of VT treated with anti-tachycardia pacing (ATP), at least one of which issymptomatic. B: ≥1 appropriate ICD shock. C: ≥3 VT episodes within 24 hr. D: Sustained VT below thedetection rate of the ICD.
Exclusion
Exclusion Criteria:
- Contraindication to VT ablation
- Renal failure (CrCl < 15 mL/min)
- NYHA IV or CCS IV angina
- STEMI within 1 month
- CABG within 3 months
- PCI within 1 month
- Pregnant
- Life expectancy < 1 year
Study Design
Study Description
Connect with a study center
Onassis Cardiac Surgery Center
Athens,
GreeceActive - Recruiting
Virgen de las Nieves University Hospital
Granada,
SpainActive - Recruiting
Arrhythmia Unit, University Hospital Ramón y Cajal
Madrid,
SpainActive - Recruiting
Basildon University Hospital
Basildon,
United KingdomActive - Recruiting
Royal Sussex County Hospital
Brighton,
United KingdomActive - Recruiting
Royal Brompton & Harefield hospital
London,
United KingdomActive - Recruiting
St Bartholomew's Hospital
London,
United KingdomActive - Recruiting
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.